# MyPaint review: brush-oriented painting and release-channel risks Canonical: https://globaltechreview.org/tech-reviews/mypaint Author: Global Tech Review Published: 2026-10-21 Updated: 2026-10-21 Sources checked: 2026-10-21 Evidence: documentation-only ## AI Summary and verdict > **AI Summary:** MyPaint lists an infinite canvas. MyPaint explicitly warns about alpha/nightly crash risks. Documentation-only, checked 2026-10-21; no product tests. [mypaint-docs] ### Verdict Evaluate MyPaint for evaluating freehand painting with the intended tablet and canvas workflow. MyPaint’s brush, canvas and tablet focus gives a concrete sketching trial to evaluate. MyPaint explicitly warns about alpha/nightly crash risks. [mypaint-docs] ## Product facts Product: MyPaint Vendor / project: MyPaint project Category: productivity Version / scope: Documentation snapshot checked 2026-10-21; repository commit fb6f7d6b1223; no installed release evaluated Website: https://github.com/mypaint/mypaint Evidence basis: documentation-only Sources checked: 2026-10-21 Verification scope and unknowns: see Evidence and methodology. - MyPaint lists an infinite canvas. (vendor-documented) [mypaint-docs] - MyPaint lists configurable brushes and graphic-tablet support. (vendor-documented) [mypaint-docs] - MyPaint lists layers, blend modes and layer groups. (vendor-documented) [mypaint-docs] - MyPaint warns that alpha releases may contain crash-causing bugs. (vendor-documented) [mypaint-docs] ## Capabilities and workflows ### Brush-oriented painting - Proposed MyPaint trial, not performed: Use a disposable canvas and the intended input device. Record build/release channel, device configuration and required brush settings. Make a repeatable set of strokes, group the required layers, save and reopen the artwork, and inspect the delivery format supported by the selected build. Retain input glitches, crashes and corrections; keep independent originals while testing prerelease builds. (editorial-opinion) [mypaint-docs] ## Strengths, limitations, and trade-offs ### Strengths - MyPaint’s brush, canvas and tablet focus gives a concrete sketching trial to evaluate. Keeping the release channel explicit makes that trial interpretable instead of treating nightly behavior as stable-release evidence. (editorial-opinion) [mypaint-docs] ### Limitations and trade-offs - For MyPaint, no drawing-speed, stability or artistic-quality ranking was measured. (editorial-opinion) [mypaint-docs] ### Conditions that affect adoption - MyPaint explicitly warns about alpha/nightly crash risks. Documented tablet and layer features do not establish actual device compatibility, file recovery or output fidelity. No drawing-speed, stability or artistic-quality ranking was measured. (editorial-opinion) [mypaint-docs] ## Best for, not for, and alternatives ### Best for - People evaluating evaluating freehand painting with the intended tablet and canvas workflow who can identify the selected release and validate the proposed sample task. [mypaint-docs] ### Not for / requirements not established - Adoption that ignores this boundary: MyPaint explicitly warns about alpha/nightly crash risks. [mypaint-docs] - A decision requiring independently established quality, recovery or security outcomes for MyPaint; those requirements were not assessed here. [mypaint-docs] ### Alternatives - For MyPaint, consider another approach or obtain more evidence when the required workflow cannot meet its written acceptance criteria. MyPaint explicitly warns about alpha/nightly crash risks. Compare alternatives using the same permitted inputs, required artifacts and failure record; this single-product source set supports no named superiority claim. (editorial-opinion) [mypaint-docs] ## Evidence and methodology Official project documentation at pinned repository commits was retrieved and matched against retained exact excerpts on 2026-10-21, under Editorial Standard 1.3, revision r1. Product assertions are attributed documentation; adoption reasoning and proposed trials are editorial inferences. No product installation, account access, hands-on test, benchmark or security experiment was performed. ### Evidence gaps and scope - Not verified: current prices, paid-plan entitlements, service quotas, contractual commitments and total operating cost. A repository description is not a current commercial quote. - Not assessed: actual task quality, performance, reliability, recovery, privacy, access enforcement or compliance. Unmentioned capabilities remain unassessed rather than absent. - Coverage is a dated project-controlled documentation snapshot, not every release, platform or edition. Proposed evaluation procedures have not been executed; public output checks are website checks, not product tests. [Evaluation framework](/methodology) ### Disclosure Sponsored: false. Affiliate links: false. The publisher confirmed on 2026-10-21 that this 30-article batch has no sponsorship or benefits for publication and no affiliate links. Codex assisted with research, drafting and automated editorial review; no product access or independent human/product testing is claimed. ### Sources - [mypaint-docs] mypaint/mypaint — official README.md (pinned snapshot): https://raw.githubusercontent.com/mypaint/mypaint/fb6f7d6b12238d125294496b105f5f36e658bc61/README.md (accessed 2026-10-21) ## FAQ and further reading ### Can a MyPaint nightly trial be generalized to the stable release? - No. MyPaint separately warns about alpha risks. Record the actual build and reproduce an important failure or success under the intended release channel before generalizing it. (editorial-opinion) [mypaint-docs] ### Further reading - [Official MyPaint product or project](https://github.com/mypaint/mypaint) - [All Tech Reviews](/tech-reviews) - [Krita vs MyPaint: painting tasks and release-channel identity](/tech-comparisons/krita-vs-mypaint) [mypaint-docs]: https://raw.githubusercontent.com/mypaint/mypaint/fb6f7d6b12238d125294496b105f5f36e658bc61/README.md